党的二十届四中全会擘画了"十五五"发展宏伟蓝图，对加快高水平科技自立自强、引领发展新质生产力作出科学部署，为做好金融"科技大文章"明确了行动 方向。人保财险各级党组织坚决贯彻党中央决策部署，落实人保集团党委工作要求，以守正创新的金融实践，推动保险保障精准覆盖"实验室—生产线—大 市场"创新全链条。 党建引领强化源头保障， "这种科研项目虽然应用前景好，但技术难度高，不确定性大。投保后，我们推进项目研发的信心和底气都更足了。"雄安新区某科创企业的负责人拿到概念 验证与小试综合保险保单后如此表示。近年来，人保财险聚焦创新起步阶段，在雄安新区、江苏、安徽、湖北等地同步签发首批概念验证与小试保险、中试 验证保险。截至2025年末，全系统为AI诊断、医疗健康等前沿领域科创项目提供风险保障超67亿元，以明确的风险兜底推动一批原始创新成果萌发落地。 党建共建聚焦产业转化， 支撑"从1到100"的跨越发展 为推动科技成果跨越产业化的"死亡之谷"，实现从实验室零星样品走向规模化生产的"从1到100"跃升，人保财险各级推动服务模式转型，对接重点实验室与 产业园区，通过联学联建开拓服务前沿阵地，共同突破成果转化的风险瓶颈。 "技术 ...

Core Viewpoint - The insurance industry is increasingly integrating with technological innovation to provide a comprehensive service system that supports the development of new productive forces by reducing innovation costs and enhancing risk management capabilities [1][2][3]. Group 1: Expansion of Service Scope - The rise of technology insurance is synchronized with technological innovation and the construction of a modern industrial system, becoming a crucial part of the technology financial system [2]. - National policies are positioning technology insurance as a foundational tool for technology finance, expanding its service scope from traditional industries to key areas such as artificial intelligence, semiconductors, biomedicine, advanced materials, and new energy [2][4]. - The importance of risk dispersion mechanisms is increasing alongside technological innovation, highlighting the dialectical unity between uncertainty exploration and certainty assurance [2]. Group 2: Market Demand and Policy Impact - The insurance industry is witnessing a significant increase in support for strategic emerging industries, with technology insurance providing over 9 trillion yuan in coverage for innovation activities in 2024, and a 30% year-on-year growth in premium income [4][5]. - Local governments are actively implementing supportive mechanisms, such as Shenzhen's plan to establish a technology insurance ecosystem and explore collaborative applications across the industrial chain [4][5]. - The interaction between policy effects and market demand is becoming more pronounced, with insurance mechanisms being integrated into the early stages of technological innovation [5]. Group 3: Embedding in the R&D Cycle - Technology insurance is addressing weak links in the R&D process by offering customized coverage for various stages, including concept validation and pilot testing, thus alleviating the financial burden on enterprises [6]. - New insurance products are being developed to cover risks associated with extreme weather, process errors, and supplier defaults, allowing R&D teams to focus on critical technological breakthroughs [6][7]. - The expansion of insurance coverage and enhanced risk identification and pricing capabilities are aligning with the needs of high-risk sectors such as semiconductors and biomedicine [6]. Group 4: Financial Support and Credit Enhancement - The insurance sector is providing long-term capital to strategic emerging industries, with investments reaching 680 billion yuan in 2024, reflecting a 17% year-on-year increase [9]. - The collaboration between insurance and investment is creating a comprehensive financial support chain for technology enterprises, enhancing their creditworthiness and facilitating smoother financing processes [9][10]. - The integration of technology insurance into financing strategies is leading to a more stable rhythm of R&D investment and smoother paths for technology commercialization [10].

Group 1 - The core viewpoint of the articles emphasizes the importance of the "first set" and "first batch" insurance policies in promoting innovation and reducing risks for manufacturers and buyers in the technology sector [1][2][3] - The implementation of the "first set" major technical equipment insurance compensation policy and the "first batch" new materials insurance compensation is aimed at addressing market promotion challenges faced by innovative products [1][2] - The insurance products are designed to provide compensation for equipment failures and losses, thereby encouraging buyers to adopt new technologies and alleviating post-sale pressures on manufacturers [1][2] Group 2 - Since 2015, China has been implementing the "first set" major technical equipment insurance compensation mechanism, which has been optimized in terms of coverage, premium rates, and application processes to better support the market entry of innovative products [2] - The insurance policies reflect a broader trend of optimizing financial services throughout the lifecycle of technology, with various financial institutions innovating products to support technology companies at different stages of development [2] - There is a growing demand for tailored financial services in the face of rapid technological innovation and the emergence of new industries, highlighting the need for improved risk management and assessment capabilities within the insurance sector [3]

Core Viewpoint - The implementation of the "first set" insurance compensation policy aims to promote innovation and alleviate market entry challenges for new technologies and materials, thereby enhancing manufacturers' confidence in research and development [1][2]. Group 1: Policy Implementation - The recent notification by relevant authorities outlines the compensation policy for the first set of major technological equipment insurance and the first batch of new materials insurance, which has garnered attention from business operators [1]. - Since 2015, China has been implementing a compensation mechanism for the first set of major technological equipment insurance, with recent optimizations in coverage, insurance rates, and application processes to better support the market entry of innovative products [2]. Group 2: Financial Support for Innovation - The first set and first batch insurance products are seen as essential components of optimizing financial services throughout the entire lifecycle of technology, supporting various stages from research and development to market promotion [2]. - Financial institutions have been innovating products and increasing support for technology companies, including the introduction of insurance for concept validation and pilot testing, which aids in transitioning technology from laboratory to production [2]. Group 3: Challenges and Recommendations - Despite the acceleration of technological innovation and the emergence of new industries, there are still shortcomings in financial service supply compared to market demand, necessitating improved risk management and assessment capabilities within the insurance industry [3]. - To enhance the effectiveness of technology finance, it is recommended to strengthen policy coordination and data sharing across departments, which would improve the willingness of enterprises to purchase insurance and expand service coverage [3].

Core Insights - The company has successfully issued its first batch of concept validation and pilot insurance, providing risk coverage for key R&D projects of eight technology enterprises and research institutions [1] - The projects are located in Xiong'an New Area, Jiangsu, Anhui, Hubei, and Liaoning, covering various fields such as AI diagnostics, healthcare, fine chemicals, optical materials, ship engineering, and pharmaceutical processing [1] - The new insurance products aim to address the challenges and uncertainties faced during the concept validation, pilot, and mid-term testing phases, helping technology companies focus on core technology development without fear of errors or setbacks [1] Product Development - The company has established a product system that covers the entire life cycle of technology activities, including R&D, achievement transformation, and application promotion [1] - Specialized risk solutions have been formed in niche sectors such as aerospace, new energy, and biomedicine [1] - The introduction of these two new products enhances the risk protection chain for early-stage technological innovation, ensuring continuous risk coverage from the early validation phase of technological achievements [1]

此次首批承保的项目，覆盖AI诊断、医疗健康、精细化工、光学材料、船舶工程、医药加工等多个前 沿领域。比如，在雄安新区，人保财险承保泛癌靶点差异化诊断项目，同时联动中国银行落地"双千 亿"中试保融通服务，为项目研发进程提供风险与资金双重支撑；在江苏，保障富硒食品研发、贴面板 设备中试项目、透明哑光玻璃中试项目及常温旋涂工艺开发项目，助力企业解决工艺难题，支撑企业拓 海外市场；在安徽，为一次性腹腔镜手术穿刺套管项目提供保险服务，解决手术安全痛点，推动医疗技 术创新。 目前，人保财险已初步构建覆盖科技研发、成果转化、应用推广的科技活动全生命周期产品体系，在航 空航天、新能源、生物医药、半导体等细分行业领域形成专属风险解决方案。此次两个新产品的推出， 进一步补全了科技创新早期阶段的保障链条，让科技成果从验证早期就获得持续的风险保障。据悉，下 一步，人保财险将持续深化科技保险产品创新，丰富全生命周期保障体系，加大对重大技术攻关、中小 科技企业创新的支持力度。 转自：新华财经 新华财经北京9月28日电（记者王虎云）近日，人保财险在雄安新区、江苏、安徽、湖北、大连等地同 步突破，成功签发全国首批概念验证与小试保险和中试验证 ...